• FPS-ZM1: Practical RAGE Inhibitor Assay Guide

  2026-08-31

  Learn how FPS-ZM1 (SKU C3723) can be used as a mechanistic RAGE inhibitor in cell viability, proliferation, cytotoxicity, and neuroinflammation experiments. This scenario-based guide connects solvent control, assay compatibility, storage, and interpretation with current RAGE research while distinguishing evidence from workflow recommendations.

• Dorsomorphin 2HCl: AMPK Workflow Guide

  2026-08-31

  Dorsomorphin 2HCl helps researchers test whether AMPK activity is causally linked to lipid metabolism, BMP signaling, osteogenesis, or hepcidin expression. This practical guide translates its dual-pathway profile into reproducible cell and preclinical workflows while highlighting solubility, selectivity, and interpretation pitfalls.

• Molidustat (BAY85-3934) Experimental Workflows

  2026-08-30

  Molidustat (BAY85-3934) enables controlled investigation of HIF stabilization, erythropoietin stimulation, and hypoxia-linked cell injury. This guide connects renal anemia therapy applications with a cardiomyocyte apoptosis model, emphasizing dose design, substrate controls, orthogonal readouts, and troubleshooting.

• Ceftolozane/Tazobactam: Mechanism and Evidence

  2026-08-29

  This review evaluates ceftolozane/tazobactam as an antipseudomonal cephalosporin and beta-lactamase inhibitor combination, integrating its PBP activity, spectrum, pharmacokinetics, pharmacodynamics, clinical trials, and tolerability. Its practical contribution is a structured framework for interpreting activity against resistant gram-negative pathogens and for translating time-dependent exposure targets into dosing decisions.

• Hexetidine (NSC-17764) Assay Workflows

  2026-08-29

  Hexetidine (NSC-17764) supports practical planktonic, biofilm, and oral-surface antimicrobial studies, but its performance depends strongly on solvent, matrix, and adsorption controls. This guide converts published mouthwash research into reproducible workflows for MIC testing, biofilm inhibition, dental plaque reduction models, and troubleshooting.

• PGF2α/PTGFR Controls Endometrial Breakdown via HIF-1α

  2026-08-28

  A 2024 mouse menstrual-like model study identifies PGF2α signaling through PTGFR as a regulator of endometrial shedding and vascular permeability after progesterone withdrawal. By combining receptor inhibition, vascular and histological readouts, and chromatin analysis, the work supports an HIF-1α–PTGFR–VEGF-A mechanism while defining important limits for translation to human menstruation.

• TSPAN18–STIM1 Signaling in Prostate Cancer Bone Metastasis

  2026-08-28

  Zhou et al. identify TSPAN18 as a stabilizer of STIM1 that prevents TRIM32-mediated ubiquitination and degradation, thereby enhancing store-operated calcium entry and prostate cancer bone metastasis. The study links a membrane protein–E3 ligase interaction to calcium-dependent tumor dissemination and provides a framework for testing STIM1-centered mechanisms in metastatic disease.

• mCherry mRNA for Kidney Nanoparticle Assays

  2026-08-27

  Explore how mCherry mRNA can function as more than a fluorescence reporter: it can help separate nanoparticle loading, cellular uptake, and translation in kidney-targeted delivery studies. This article connects Cap 1 and modified-nucleotide chemistry with practical assay design and formulation quality control.

• Pam3CSK4 TLR1/2 Agonist Workflow Guide

  2026-08-27

  Build reproducible innate immune activation assays with Pam3CSK4, from macrophage nitric oxide production to cytokine profiling and allergy models. The workflow also shows how to pair a defined TLR1/2 stimulus with sensory-nerve interventions without confusing an established immune assay with a hypothesis-generating neuro-immune extension.

• Cisplatin Beyond Cytotoxicity: A Translational Playbook

  2026-08-26

  Cisplatin, or CDDP, is more than a cytotoxic benchmark. Its DNA crosslinking, p53–caspase signaling, and oxidative stress create a powerful framework for cancer research, while cisplatin-induced renal fibrosis reveals why translational programs must measure both antitumor activity and tissue injury. This guide connects mechanistic biology with practical assay design, xenograft interpretation, resistance studies, and a more integrated view of therapeutic index.

• Cytarabine and Translational Cell-Death Logic

  2026-08-26

  Cytarabine and AraC are more than broad cytotoxic tools: their dependence on deoxycytidine kinase activation creates a tractable framework for studying DNA synthesis inhibition, resistance, apoptosis, and translational cell-death biology. This article connects leukemia research workflows with emerging insights from viral necroptosis research while clearly separating established evidence from hypothesis-generating opportunities.

• YM-155 hydrochloride Survivin Inhibitor Workflows

  2026-08-25

  Build more informative cancer-drug assays with YM-155 hydrochloride by separating growth arrest from true cell killing. This workflow combines selective survivin suppression, time-resolved viability measurements, and practical formulation controls for apoptosis inhibitor research and xenograft-oriented model selection.

• Testosterone Bounce in Degarelix-Treated Prostate Cancer

  2026-08-25

  A 2024 study found that a testosterone bounce above 20 ng/dL after reaching a nadir below that threshold was associated with longer overall and cancer-specific survival in men receiving degarelix. The result identifies a readily measurable testosterone trajectory that may complement PSA-based assessment, while its retrospective design requires prospective validation before clinical adoption.

• TBST for High-Signal Immunoassay Workflows

  2026-08-24

  TBST combines buffered salt conditions with Tween 20 to reduce nonspecific binding in Western blotting, immunofluorescence, immunohistochemistry, and immunocytochemistry. This guide translates that practical advantage into reproducible workflows for studying conformationally dynamic targets such as the uPAR–uPA interaction.

• GRE Suppresses Melanogenesis via CREB/MITF

  2026-08-23

  The reference study examines glabridin, resveratrol, and ellagic acid as a combined GRE composition with anti-melanogenic, antioxidant, and anti-inflammatory activity in cell-based assays. Its principal mechanistic contribution is connecting reduced melanin production with inhibition of CREB phosphorylation and downstream MITF-associated pigmentation programs, while also defining important limits for translation to hyperpigmentation disorders.

450 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page